DE60202474D1 - Antarticine-nf3 zur behandlung und reepithelialisierung von wunden - Google Patents

Antarticine-nf3 zur behandlung und reepithelialisierung von wunden

Info

Publication number
DE60202474D1
DE60202474D1 DE60202474T DE60202474T DE60202474D1 DE 60202474 D1 DE60202474 D1 DE 60202474D1 DE 60202474 T DE60202474 T DE 60202474T DE 60202474 T DE60202474 T DE 60202474T DE 60202474 D1 DE60202474 D1 DE 60202474D1
Authority
DE
Germany
Prior art keywords
wounds
treatment
antarticine
reepithelialization
adhesion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60202474T
Other languages
English (en)
Other versions
DE60202474T2 (de
Inventor
Duena Antonio Parente
Garces Josep Garces
Sanchez Jesus Guinea
Anton Josep Maria Garcia
Marano Ricardo Casaroli
Del Pozo Manuel Reina
Coma Senen Vilaro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lipotec SA
Original Assignee
Lipotec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec SA filed Critical Lipotec SA
Publication of DE60202474D1 publication Critical patent/DE60202474D1/de
Application granted granted Critical
Publication of DE60202474T2 publication Critical patent/DE60202474T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
DE60202474T 2001-06-14 2002-06-07 Antarticine-nf3 zur behandlung und reepithelialisierung von wunden Expired - Lifetime DE60202474T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200101383A ES2181592B1 (es) 2001-06-14 2001-06-14 Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas
ES200101383 2001-06-14
PCT/ES2002/000281 WO2002102406A1 (es) 2001-06-14 2002-06-07 Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas

Publications (2)

Publication Number Publication Date
DE60202474D1 true DE60202474D1 (de) 2005-02-03
DE60202474T2 DE60202474T2 (de) 2005-12-29

Family

ID=8498066

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60202474T Expired - Lifetime DE60202474T2 (de) 2001-06-14 2002-06-07 Antarticine-nf3 zur behandlung und reepithelialisierung von wunden

Country Status (12)

Country Link
US (1) US7022668B2 (de)
EP (1) EP1402898B1 (de)
JP (1) JP4252444B2 (de)
KR (1) KR20040030675A (de)
AT (1) ATE285787T1 (de)
BR (1) BRPI0210428B8 (de)
CA (1) CA2449910C (de)
DE (1) DE60202474T2 (de)
ES (2) ES2181592B1 (de)
MX (1) MXPA03011622A (de)
PT (1) PT1402898E (de)
WO (1) WO2002102406A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100784486B1 (ko) * 2007-01-08 2007-12-11 주식회사 에스티씨나라 피부 타이트닝용 화장료 조성물 및 이를 이용한 피부타이트닝 방법
KR101126314B1 (ko) 2007-11-15 2012-03-23 한국해양연구원 항동결능을 가지는 신규 세포외다당체
ES2336995B1 (es) * 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
ES2390033B1 (es) * 2010-11-30 2013-10-31 Lipotec S.A. Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas.
WO2013121002A1 (en) 2012-02-16 2013-08-22 Arquebio, S. L. Microorganism-free extract from hypersaline aqueous environments and process for its preparation
WO2015063613A2 (en) 2013-11-01 2015-05-07 Spherium Biomed S.L. Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
WO2016066857A1 (en) * 2014-10-31 2016-05-06 Lipotec, S.A.U. Cosmetic and/or pharmaceutical composition containing a bacterial extracellular product from pseudoalteromonas antarctica, and use thereof
EP3165233B1 (de) 2015-08-28 2021-08-18 Latvijas Universitate Biomaterial zur behandlung von akuten und chronischen hautwunden
KR102311724B1 (ko) 2017-09-15 2021-10-13 (주)아모레퍼시픽 슈도알터로모나스 펩티도라이티카의 배양물 또는 이의 추출물을 포함하는 피부 미백용 조성물
KR102395984B1 (ko) 2017-09-27 2022-05-11 (주)아모레퍼시픽 슈도알터로모나스 카라기노보라의 배양물 또는 이의 추출물을 포함하는 피부 미백용 조성물
EP3790568A1 (de) 2018-05-08 2021-03-17 Gat Biosciences, S.L. Imac-angereicherter mikroalgenkulturüberstand und verwendungen davon

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2126516B1 (es) * 1997-03-26 1999-12-01 Univ Barcelona Glicoproteina para proteccion de liposomas.

Also Published As

Publication number Publication date
EP1402898B1 (de) 2004-12-29
EP1402898A1 (de) 2004-03-31
ES2236525T3 (es) 2005-07-16
JP4252444B2 (ja) 2009-04-08
BRPI0210428B8 (pt) 2021-05-25
ATE285787T1 (de) 2005-01-15
BR0210428A (pt) 2004-08-17
KR20040030675A (ko) 2004-04-09
ES2181592B1 (es) 2003-11-01
MXPA03011622A (es) 2004-07-01
PT1402898E (pt) 2005-05-31
US7022668B2 (en) 2006-04-04
ES2181592A1 (es) 2003-02-16
BRPI0210428B1 (pt) 2018-04-17
DE60202474T2 (de) 2005-12-29
WO2002102406A1 (es) 2002-12-27
CA2449910A1 (en) 2002-12-27
CA2449910C (en) 2013-01-08
JP2004534076A (ja) 2004-11-11
US20040242466A1 (en) 2004-12-02

Similar Documents

Publication Publication Date Title
US10844101B2 (en) Plant-derived elastin binding protein ligands and methods of using the same
EP1265570B1 (de) Lösliches keratinpeptid
AU719089B2 (en) Pharmaceutical composition containing IL-10
JPH04224522A (ja) 繊維芽細胞増殖因子含有組成物による禿頭症の治療又は予防方法
US20130095061A1 (en) Umbilical cord stem cell secreted product derived topical compositions and methods of use thereof
ATE285787T1 (de) Antarticine-nf3 zur behandlung und reepithelialisierung von wunden
US20120034183A1 (en) Compositions and methods for growing embryonic stem cells
GB2146335A (en) Wound healing compositions
AU2006203246A1 (en) Compositions and methods for regulating phagocytosis and ICAM-1 expression
KR960701648A (ko) Pdgf와 비타민 d를 함유하는 조골세포 성장 자극 조성물(oesteoblast growth stimulating compostion containing pdgf and vitamind)
AU4727889A (en) A novel purified thrombomodulin-like glycoprotein obtained from urine.
EP0447414B1 (de) Verwendung von minoxidil zur wundheilung
DE60113167D1 (de) Verwendung von Verbindungen zur Modifizierung der physico-chemischen Eigenschaften der Haut und/oder der Schleimhaut als Mittel zur Verhinderung oder Reduzierung der Adhäsion von Mikro-organismen darauf
JP5762670B2 (ja) Ｌｏｐａｐをベースとする医薬組成物およびその使用
EP1719522B1 (de) TCF-II enthaltende medizinische Zusammensetzung
Ramamurthy et al. Topically applied CMT-2 enhances wound healing in streptozotocin diabetic rat skin
WO2008082523A1 (en) Stem cell secreted product derived compositions for wound treatment
Kaneko et al. Prostaglandin I 1 analogues, SM-10902 and SM-10906, affect human keratinocytes and fibroblasts in vitro in a manner similar to PGE 1: therapeutic potential for wound healing
WO2005077402A1 (en) Honey based gel formulations
Harvey et al. In vitro inhibition of lipopolysaccharide-induced bone resorption by polymyxin B.
Köveker et al. The role of wound healing in the formation of peritoneal adhesions
Siddiqui et al. Theory of growth factors and ulcer healing
IL120696A (en) Component b as cicatrizant
JP2004238374A (ja) 抗クラミジア用剤
WO2013014687A1 (en) Plantaricins and biomass comprising plantaricins for use in cosmetic and medical fields

Legal Events

Date Code Title Description
8364 No opposition during term of opposition